Therapeutic pathology
11 – 20 of 160
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Serine-arginine protein kinase 1 (SRPK1) is under-expressed in mucinous colorectal cancer, and may mediate resistance to oxaliplatin
Duggan, William P ; Azimi, Mohammedreza ; Flanagan, Lyndsey ; Sullivan, Graeme P ; Reynolds, Ian S ; Fay, Joanna ; Dussmann, Heiko ; Ní Chonghaile, Tríona ; Sheehan, Katherine M and Jirström, Karin LU
, et al.
(2025)
In Pharmacogenomics Journal
25(5).
p.1-10
- Contribution to journal › Article
- 2024
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
Malmros, Karina LU ; Lindholm, Andreas ; Vidarsdottir, Halla LU ; Jirström, Karin LU
; Nodin, Björn
LU
; Botling, Johan
; Mattsson, Johanna S.M.
; Micke, Patrick
; Planck, Maria
LU
and Jönsson, Mats
LU
, et al.
(2024)
In Virchows Archiv
485.
p.347-357
- Contribution to journal › Article
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
Huss, Linnea LU ; Gulz-Haake, Igis LU ; Nilsson, Emma LU ; Tryggvadottir, Helga LU ; Nilsson, Linn LU ; Nodin, Björn LU ; Jirström, Karin LU
; Isaksson, Karolin
LU
and Jernström, Helena
LU
(2024)
In Nutrients
16(7).
p.1-15
- Contribution to journal › Article
-
Mark
Quality of life for patients with advanced gastrointestinal cancer randomised to early specialised home-based palliative care: the ALLAN trial
- Contribution to journal › Article
-
Mark
Pancreatic cancer evolution across space and time: From diagnosis to terminal disease
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
Nobin, Hampus LU ; Garvin, Stina ; Hagman, Helga LU
; Nodin, Björn
LU
; Jirström, Karin
LU
and Brunnström, Hans
LU
(2024)
In BMC Cancer
24.
p.1-16
- Contribution to journal › Article
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
Godina, Christopher LU
; Khazaei, Somayeh
LU
; Belting, Mattias
LU
; Vallon-Christersson, Johan
LU
; Nodin, Björn
LU
; Jirström, Karin
LU
; Isaksson, Karolin
LU
; Bosch, Ana
LU
and Jernström, Helena
LU
(2024)
In PLoS ONE
19(7).
p.1-21
- Contribution to journal › Article
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
Nilsson, Linn LU ; Khazaei, Somayeh LU ; Tryggvadottir, Helga LU ; Björner, Sofie LU ; Bressan, Alessandra ; Jirström, Karin LU
; Adrian, Gabriel
LU
; Falck, Anna-Karin
LU
; Borgquist, Signe
LU
and Isaksson, Karolin
LU
, et al.
(2024)
In Clinical Breast Cancer
24(3).
p.152-166
- Contribution to journal › Article
-
Mark
AIRE is expressed in breast cancer TANs and TAMs to regulate the extrinsic apoptotic pathway and inflammation
Källberg, Eva LU ; Mehmeti-Ajradini, Meliha LU ; Gunnarsdottir, Frida Björk LU ; Göransson, Marcus ; Bergenfelz, Caroline LU
; Fredriksson, Roni Allaoui
; Hagerling, Catharina
LU
; Johansson, Martin E
LU
; Welinder, Charlotte
LU
and Jirström, Karin
LU
, et al.
(2024)
In Journal of Leukocyte Biology
115(4).
p.664-678
- Contribution to journal › Article
-
Mark
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma
Papadakos, Konstantinos S LU
; Gorji-Bahri, Gilar
LU
; Gialeli, Chrysostomi
LU
; Hedner, Charlotta
LU
; Hagerling, Catharina
LU
; Svensson, Maria C
LU
; Jeremiasen, Martin
LU
; Borg, David
LU
; Fristedt, Richard
LU
and Jirström, Karin
LU
, et al.
(2024)
In Cancer Immunology Immunotherapy
73(5).
- Contribution to journal › Article